Barbara Izzo

2.9k total citations
40 papers, 1.5k citations indexed

About

Barbara Izzo is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Barbara Izzo has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Hematology, 22 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Barbara Izzo's work include Chronic Myeloid Leukemia Treatments (25 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Acute Myeloid Leukemia Research (10 papers). Barbara Izzo is often cited by papers focused on Chronic Myeloid Leukemia Treatments (25 papers), Chronic Lymphocytic Leukemia Research (17 papers) and Acute Myeloid Leukemia Research (10 papers). Barbara Izzo collaborates with scholars based in Italy, United States and Australia. Barbara Izzo's co-authors include Fabrizio Pane, Giuseppe Saglio, Giovanni Martinelli, Michele Baccarani, Marilina Amabile, Gianantonio Rosti, Simona Soverini, Angela Poerio, Fausto Castagnetti and Elisabetta Abruzzese and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Barbara Izzo

35 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Barbara Izzo Italy 15 1.3k 812 515 364 339 40 1.5k
Sélim Corm France 18 1.0k 0.8× 715 0.9× 444 0.9× 199 0.5× 232 0.7× 44 1.4k
Ghayas C. Issa United States 24 1.5k 1.2× 631 0.8× 207 0.4× 751 2.1× 652 1.9× 146 2.1k
Anna Serra Italy 21 658 0.5× 460 0.6× 113 0.2× 237 0.7× 475 1.4× 64 1.2k
M Giralt Spain 19 638 0.5× 604 0.7× 186 0.4× 100 0.3× 522 1.5× 50 1.7k
Nicola Goekbuget Germany 19 464 0.4× 147 0.2× 84 0.2× 895 2.5× 332 1.0× 68 1.3k
Gregor Eisenwort Austria 20 427 0.3× 266 0.3× 171 0.3× 47 0.1× 303 0.9× 54 1.0k
Krzysztof Jamroziak Poland 20 277 0.2× 473 0.6× 46 0.1× 157 0.4× 357 1.1× 106 1.1k
Mariadomenica Divona Italy 19 868 0.7× 165 0.2× 34 0.1× 335 0.9× 800 2.4× 49 1.2k
Victoria Bedell United States 16 218 0.2× 156 0.2× 54 0.1× 153 0.4× 431 1.3× 40 1.0k
Sarah Moore Australia 12 265 0.2× 173 0.2× 86 0.2× 74 0.2× 175 0.5× 32 563

Countries citing papers authored by Barbara Izzo

Since Specialization
Citations

This map shows the geographic impact of Barbara Izzo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Izzo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Izzo more than expected).

Fields of papers citing papers by Barbara Izzo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Izzo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Izzo. The network helps show where Barbara Izzo may publish in the future.

Co-authorship network of co-authors of Barbara Izzo

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara Izzo. A scholar is included among the top collaborators of Barbara Izzo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara Izzo. Barbara Izzo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Giudice, Valentina, Bianca Serio, Santa Errichiello, et al.. (2023). Subclones with variants of uncertain clinical significance might contribute to ineffective hemopoiesis and leukemia predisposition. European Journal Of Haematology. 111(5). 729–741. 4 indexed citations
3.
Giudice, Valentina, Marisa Gorrese, A. Bertolini, et al.. (2022). c-Kit M541L variant is related to ineffective hemopoiesis predisposing to clonal evolution in 3D in vitro biomimetic co-culture model of bone marrow niche. Heliyon. 8(12). e11998–e11998. 5 indexed citations
4.
Giudice, Valentina, Marisa Gorrese, A. Bertolini, et al.. (2021). WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes. Biomedicines. 9(4). 387–387. 11 indexed citations
5.
Bochicchio, Maria Teresa, Jessica Petiti, Paola Berchialla, et al.. (2021). Droplet Digital PCR for BCR–ABL1 Monitoring in Diagnostic Routine: Ready to Start?. Cancers. 13(21). 5470–5470. 9 indexed citations
6.
Stella, Stefania, Eva Barragán, Santa Errichiello, et al.. (2019). The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias. International Journal of Molecular Sciences. 20(24). 6106–6106. 10 indexed citations
7.
Fava, Carmen, Paola Berchialla, Jessica Petiti, et al.. (2019). A Comparison of Droplet Digital PCR and RT-qPCR for BCR-ABL1 Monitoring in Chronic Myeloid Leukemia. Blood. 134(Supplement_1). 2092–2092. 3 indexed citations
8.
Izzo, Barbara, et al.. (2019). Monitoring Chronic Myeloid Leukemia: How Molecular Tools May Drive Therapeutic Approaches. Frontiers in Oncology. 9. 833–833. 15 indexed citations
9.
Marino, Luigi, Fabrizio Dal Piaz, Barbara Izzo, et al.. (2019). Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples. Analytical Letters. 52(8). 1328–1339. 14 indexed citations
10.
Daraio, Filomena, Emilia Giugliano, Carmen Fava, et al.. (2017). An Italian Multicentre Study Using Different Digital PCR Instruments on BCR-ABL1 Positive Patients at Different Levels of CML Disease. Blood. 130. 4176–4176. 1 indexed citations
11.
Zarrilli, Federica, Rossella Tomaiuolo, Barbara Lombardo, et al.. (2014). Molecular Analysis of Cluster Headache. Clinical Journal of Pain. 31(1). 52–57. 27 indexed citations
12.
Pugliese, Nicola Riccardo, Luana Marano, C. Quintarelli, et al.. (2012). Effectiveness of Interferon Alpha Therapy in Essential Thrombocythemia.
13.
Alimena, Giuliana, Massimo Breccia, Luigia Luciano, et al.. (2007). Imatinib mesylate therapy in chronic myeloid leukemia patients in stable complete cytogenic response after interferon-alpha results in a very high complete molecular response rate. Leukemia Research. 32(2). 255–261. 9 indexed citations
14.
15.
Ferrara, Felicetto, Salvatore Palmieri, Catia Lo Pardo, et al.. (2006). Presence of FLT3 Mutations Does Not Impair Stem Cell Mobilization and Feasibility of Autologous Peripheral Blood Stem Cell Transplantation in Acute Myeloid Leukemia. Biology of Blood and Marrow Transplantation. 12(9). 981–986. 8 indexed citations
16.
17.
Rosti, Gianantonio, Giovanni Martinelli, Simona Bassi, et al.. (2003). Molecular response to imatinib in late chronic-phase chronic myeloid leukemia. Blood. 103(6). 2284–2290. 56 indexed citations
18.
Pane, Fabrizio, et al.. (2002). BCR/ABL genes and leukemic phenotype: from molecular mechanisms to clinical correlations. Oncogene. 21(56). 8652–8667. 85 indexed citations
19.
Noto, Rosa Di, Fabrizio Pane, Antonio Camera, et al.. (2001). Characterization of two novel cell lines, DERL-2 (CD56+/CD3+/TCRγδ+) and DERL-7 (CD56+/CD3−/TCRγδ−), derived from a single patient with CD56+ non-Hodgkin's lymphoma. Leukemia. 15(10). 1641–1649. 21 indexed citations
20.
Volpe, Pietro, Barbara Izzo, Marco Russo, & Luigi Iannetti. (2001). Intrauterine device for contraception in dogs. Veterinary Record. 149(3). 77–79. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sélim Corm Breakdown of academic impact, for papers by Ghayas C. Issa Breakdown of academic impact, for papers by Anna Serra Breakdown of academic impact, for papers by M Giralt Breakdown of academic impact, for papers by Nicola Goekbuget Breakdown of academic impact, for papers by Gregor Eisenwort Breakdown of academic impact, for papers by Krzysztof Jamroziak Breakdown of academic impact, for papers by Mariadomenica Divona Breakdown of academic impact, for papers by Victoria Bedell Breakdown of academic impact, for papers by Sarah Moore
Rankless by CCL
2026